Diabetes drug gets mixed review

Diabetes drug gets mixed review
FDA panel links Avandia to health risks but majority recommends it stay on the market. Diabetes mellitus – Rosiglitazone – Health – Food and Drug Administration – Conditions and Diseases

Read more on Washington Post

Tags: diabetes, drug, gets, mixed, Review

Leave a Reply